Displaying 1 - 9 of 9
Metabolism, Alcohol & Toxicity
1

Novo Nordisk: "Walking the clinical care pathway for NASH: learnings from implementation" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
1

Mirum Pharmaceuticals, Inc: "Meet the Experts in Cholestatic Liver Disease" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
1

Novo Nordisk and Echosens: "Clinical challenge: Updates on the non-invasive toolbox for NASH and Fibrosis" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
6

Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
6

Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
6

Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
6

Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
6

Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
6

Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023

View
Displaying 1 - 9 of 9